Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01721473 · ClinicalTrials.gov registry record
Brain Nicotine Receptor Density in Veteran Smokers
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 184
- Enrollment target
NCT01721473: Completed study, sponsored by VA Office of Research and Development.
NCT01721473 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 184 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01721473 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 184 participants
- Enrollment target
Study Summary
Cigarette smoking is more prevalent among Veterans (27%) than the general U.S. population (21%). Smoking is common among people who use marijuana or caffeine heavily, and the use of menthol cigarettes is becoming increasingly common, affecting approximately 9% of the Veteran population. Recent research by the group and others indicates that heavy marijuana or caffeine use, or the use of predominantly menthol cigarettes, can alter brain nicotinic acetylcholine receptor (nAChR) densities. For the proposed study, brain imaging with PET scanning will be used to determine nicotine receptor densities in Veteran cigarette smokers with and without heavy marijuana or caffeine use, and in menthol and non-menthol Veteran smokers. Results of the proposed research may have implications for improving treatments for Veterans who smoke cigarettes and who have specific drug use co-morbidities or who use menthol cigarettes.
Interventions
- OTHER positron emission tomography scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2012-01-01 |
| Est. Completion | 2016-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01721473
The ClinicalTrials.gov registry entry for NCT01721473 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 184 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which positron emission tomography scan is the first listed.
NCT01721473 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01721473 about?
NCT01721473 is a clinical study titled "Brain Nicotine Receptor Density in Veteran Smokers". Cigarette smoking is more prevalent among Veterans (27%) than the general U.S. population (21%). Smoking is common among people who use marijuana or caffeine heavily, and the use of menthol cigarettes is becoming increasingly common, affecting approximately 9% of the Veteran population. Recent resea...
What is the current status of trial NCT01721473?
This trial is currently completed. The enrollment target is 184 participants. The study started on 2012-01-01. Estimated completion is 2016-06-30.
What interventions are being tested in trial NCT01721473?
The interventions under investigation include: positron emission tomography scan (OTHER).
Who is sponsoring clinical trial NCT01721473?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.